BREAKING NEWS: Endurance Specialty to Buy Montpelier Re for About $1.83 Billion

Bloomberg - Home Search
Bristol-Myers Squibb Co (BMY:US)
update Mar 30
65.76 +0.50 (+0.77%)
High 66.12
Low 65.29
Open 65.57
Volume 4159215
Time Mar 30
intra-day chart
High 69.20
Low 46.30
P/E 47.73
Return +30.14%
Mkt Cap 109.6 B
one year chart
Company News
Company Profile
Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.